15-min delayed · Sep 9, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 24 firms covering Amgen Inc, 10 rate it Buy or better, 12 sit at Hold, and 2 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $345.00 to $460.00, so the covering firms are broadly aligned. The average target of $401.20 sits 3% above the current $391.36. Sentiment has cooled somewhat, with Sell ratings rising from 1 to 2 over recent months. On the fundamentals, the Street sees revenue growth near 3% this year and 3% next, consensus EPS building from about $5.80 next quarter toward $24.41 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS24 ratings
Moderate Buy
Strong Buy00%
Buy1042%
Hold1250%
Sell28%
Strong Sell00%
Based on 24 analysts giving stock ratings to Amgen Inc.
As of Sep, 10 of 24 firms rate AMGN a Buy (12 Hold, 2 Sell), the standing distribution of every covering firm's most recent active call.
AMGN EPS & revenue forecast
EPS · NEXT QUARTER
$5.80
Range $5.19 – $6.29 · 27 analysts · +10% YoY
Next period, 27 analysts expect Amgen Inc to earn $5.80 a share (range $5.19 – $6.29), versus $5.29 a year earlier. Full-year consensus is $23.04, growing to $24.41 the year after.
REVENUE · NEXT QUARTER
$10.3B
Range $9.9B – $10.6B · 27 analysts · +1% YoY
Revenue is expected to reach $10.3B (range $9.9B – $10.6B), +1.0% year-over-year. Full-year consensus is $38.9B, rising to $40.2B next year.
Top analysts covering Amgen Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on AMGN.
#1
Luca Issi
RBC Capital · Rank #1
Buy
$400.00+2.2% to target
Overall win rate
55%
+ Follow
#2
David Amsellem
Piper Sandler · Rank #107
Buy
$457.00+16.8% to target
Overall win rate
50%
+ Follow
#3
TA
Tazeen Ahmad
B of A Securities · Rank #317
Sell
$317.00-19.0% to target
Overall win rate
47%
+ Follow
#4
Jay Olson
Oppenheimer · Rank #360
Buy
$450.00+15.0% to target
Overall win rate
33%
+ Follow
#5
Terence Flynn
Morgan Stanley
Hold
$362.00-7.5% to target
Coverage
—
+ Follow
AMGN stock forecast FAQ
What is AMGN's average 12-month price target?+
The 20 analysts with a live target average $401.20 for Amgen Inc over the next 12 months, ranging from a $460.00 high to a $345.00 low.
Is AMGN stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 24 analyst ratings, 10 are Buy or Strong Buy, 12 are Hold, and 2 are Sell or Strong Sell.
What are the highest and lowest price targets for AMGN?+
The Street-high target is $460.00 (Argus Research), and the Street-low is $345.00 (Bernstein). The average of all 20 active targets is $401.20.
How many Wall Street analysts cover AMGN?+
24 analysts have an active rating on Amgen Inc, and 20 firms carry a live 12-month price target.
Who is the most accurate analyst covering AMGN?+
Among analysts who currently cover AMGN, Luca Issi of RBC Capital has the strongest overall Quantellect track record (Rank #1). Their current call is Buy with a $400.00 target.
What is Amgen Inc's projected EPS for next quarter?+
The consensus estimate is $5.80 per share (range $5.19 – $6.29) across 27 analysts. Full-year EPS is projected at $23.04, rising to $24.41 the following year.
How much revenue is Amgen Inc expected to report next quarter?+
Consensus revenue is $10.3B (range $9.9B – $10.6B). Full-year revenue is projected at $38.9B, growing to $40.2B next year.
Have analysts been upgrading or downgrading AMGN lately?+
As of Sep, 10 of 24 firms rate AMGN a Buy (12 Hold, 2 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their AMGN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
